m-Doxazosin Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

m-doxazosin

multichem nz limited - doxazosin mesilate 1.213mg equivalent to doxazosin 1 mg - tablet - 1 mg - active: doxazosin mesilate 1.213mg equivalent to doxazosin 1 mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate sodium starch glycolate

m-Doxazosin Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

m-doxazosin

multichem nz limited - doxazosin mesilate 2.426mg equivalent to doxazosin 2 mg - tablet - 2 mg - active: doxazosin mesilate 2.426mg equivalent to doxazosin 2 mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose sodium laurilsulfate sodium starch glycolate

Doxazosin Aurobindo Tablets 4mg Malta - englanti - Medicines Authority

doxazosin aurobindo tablets 4mg

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - doxazosin - tablet - doxazosin 4 mg - antihypertensives

Apo-Doxazosin Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

apo-doxazosin

apotex nz ltd - doxazosin mesilate 1.22mg equivalent to 1 mg doxazosin;   - tablet - 1 mg - active: doxazosin mesilate 1.22mg equivalent to 1 mg doxazosin   excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - doxazosin is indicated for the treatment of hypertension and can be used as the initial agent to control pressure in the majority of patients. for patients who are not adequately controlled on a singel antihypertensive agent, doxazosin can be used in combination with another agent such as a thiazide diuretic, a beta-blocker, a calcium antagonist or an angiotensin-converting enzyme inhibitor.